Enzymit

Cell-free Bioproduction

Agriculture & Food Technologies
Private
Follow

Company Overview

Snapshot

Founded in June 2020 by Gideon Lapidoth and Dror Baran, Enzymit operates with 11–50 employees. The company has raised $17 million across 5 funding rounds from 8 investors. In September 2024, Enzymit secured Series A funding with participation from lead investors Khosla Ventures.

Business overview

Enzymit is a bioproduction platform company that develops cell-free enzymatic manufacturing technology to enhance the speed, simplicity, cost-effectiveness, and sustainability of bioproduction. The company's proprietary technology integrates complex computational design algorithms, deep-learning algorithms, and experimental tools to engineer novel enzymes. Enzymit primarily serves industries within Agriculture & Food Technologies, aiming to replace traditional chemical manufacturing with greener, more efficient enzymatic processes.

Strategic signal

In November 2025, Enzymit achieved the world's first scaled cell-free production of hyaluronic acid, a significant milestone that demonstrates the commercial viability and scalability of its biomanufacturing technology. This accomplishment, highlighted by multiple industry publications, signals a strong validation of Enzymit's platform and its potential to disrupt traditional chemical manufacturing processes across various sectors, including cosmetics and pharmaceuticals.

Log in to access full profile

Company Intelligence Q&A

What was a significant recent product development for Enzymit?
In November 2025, Enzymit achieved the world's first scaled cell-free production of hyaluronic acid, pioneering a novel biomanufacturing process in collaboration with Cosun.
When did Enzymit secure its Series A funding round?
Enzymit secured its Series A funding round in September 2024, with Khosla Ventures and Grove Ventures participating as lead investors.
What was a key strategic partnership for Enzymit in 2023?
In May 2023, Enzymit partnered with Aleph Farms to reduce production costs and shorten the time-to-market for cultivated meat, leveraging its bioproduction technology.
What recognition did Enzymit receive from the World Economic Forum?
In June 2024, Enzymit was recognized as one of the 2024 Technology Pioneers by the World Economic Forum, highlighting its innovative contributions to technology.
What research did Enzymit publish in August 2023?
In August 2023, new research demonstrated the application of Enzymit's deep learning technology for novel biocatalysis design, showcasing its potential to transform enzyme design and catalyze cell-free bioproduction across multiple industries.
Log in to access full profile